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Abstract
Background: Diseases caused by Helicobacter pylori infection, including gastritis and gastric ulcer, can be harmful to epithelial cells
in gastric mucosa. Furthermore, pro-inflammatory cytokines can affect the severity of some diseases caused by H. pylori infection.
NLRP3 inflammasome detects H. pylori and activates caspase-1 that leads to the release of interleukin-1β (IL-1β) and interleukin-18
(IL-18) in the stomach.
Objectives: Since genetic variations such as polymorphisms may be involved in the expression of genes, this study was conducted
to investigate the effect of NLRP3 rs10754558 polymorphism in pathogenesis of H. pylori infection.
Methods: Four hundred and sixty-four Iranian patients (300 patients infected with H. pylori and 164 patients uninfected with H.
pylori) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Cytokine mRNA and
protein expression were evaluated in patients infected with different genotypes of NLRP3 rs10754558 using real time-PCR and west-
ern blotting, respectively.
Results: The NLRP3 rs10754558 gene polymorphism was not associated with H. pylori infection or diseases caused by this bacterium.
It was found out that the level of IL-1β in patients infected was higher than the uninfected individuals. Moreover, no relation was
found between these single nucleotide polymorphisms and cytokine expression in H. pylori infected subjects. The findings of this
study show that NLRP3 rs10754558 polymorphism may be related to the severity of acute inflammation in these patients.
Conclusions: Our findings show that rs10754558 polymorphism might not participate in regulating inflammation and immune
responses in patients with H. pylori by influencing the expression of components of the NLRP3 inflammasome.
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1. Background
Helicobacter pylori as a Gram-negative facultative intra-
cellular organism is able to move to the gastric mucosa
due to its spiral form and leads to infection in gastric mu-
cosa (1, 2). The prevalence of H. pylori infection is high and
half of the world’s population is involved with this bac-
terium (3, 4). The colonization of this bacterium in the
stomach is more likely to occur in people with chronic in-
flammation (5). Since most cases of H. pylori infection oc-
cur without any clinical symptoms, most people are un-
aware of this infection (3). However, the clinical manifes-
tations, including gastroduodenal ulcer, gastritis, mucosa-
associated lymphoid tissue (MALT) lymphoma and gastric
adenocarcinoma may be observed in most cases (6, 7).
Biopsy of H. pylori-infected individual has high level of
immune cells infiltrate, including neutrophils, dendritic
cells, monocytes, mast cells, and various types of lympho-
cytes and also pro-inflammatory cytokines, including in-
terleukins (IL-1, IL-6 and IL-8), tumor necrosis factor-α (TNF-
α), in comparison with uninfected people (8). In almost all
individuals involved with H. pylori bacteria, the humoral
and cellular immune responses occur simultaneously (9,
10). Microorganisms colonized in epithelial mucosa, such
as H. pylori, are detected by pattern recognition recep-
tors (PRRs) involved in the innate immunity. So, these re-
ceptors recognize the protected patterns found in many
pathogens (11). NLRP3, is the most inflammasome complex
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that plays a critical role in inducing inflammation by re-
cruiting adaptor proteins, and subsequently, triggers the
caspase 1 protein, specific cysteine, and aspartate protease
(12). The activation of caspase in the infected individuals is
able to express certain inflammatory cytokines, including
IL-1β and IL-18, in the dendritic cells; the presence of these
two cytokines can lead to exacerbate inflammation (12-14).
NLRP3 gene is located on the short arm of chromosome
1 (1q44) and contains 9 exon codes (15). Some studies have
shown that polymorphisms in PRRs genes may influence
cytokine expression category in gastric mucosa of H. py-
lori-infected patients with gastritis (16). NLRP3 rs10754558
polymorphism has been associated with poor prognosis of
coronary artery disease (CAD) in the Chinese population of
Han. In addition, the G allele may be associated with an
increase in the serum level of IL-1β (17). While other stud-
ies didn’t find any relationship between NLRP3 rs10754558
polymorphism and inflammatory diseases such as inflam-
matory bowel disease (IBD), Crohn disease, and gout (18,
19). The purpose of our study was to analyze the associa-
tion of NLRP3 rs10754558 polymorphism with gastritis and
peptic ulcer disease and to evaluate the effect of this poly-
morphism on the expression of IL-1β cytokine in H. pylori-
infected patients.
2. Objectives
Since genetic variations such as polymorphisms may
be involved in the expression of genes, this study was con-
ducted to investigate the effect of NLRP3 rs10754558 poly-
morphism in pathogenesis of H. pylori infection.
3. Methods
3.1. Patients
To investigate the polymorphism of NLRP3 gene in pa-
tients with H. pylori-infection, 464 patients with dyspepsia
participated in the study. Informed consent was obtained
before biopsy sampling from the antral parts of the stom-
ach. Five biopsy samples were obtained from the gastric
antrum in each patient, which were then tested respec-
tively for rapid urease, DNA extraction, RNA extraction,
protein extraction, and histopathology study.
3.2. Detection of Helicobacter pylori
The histological examinations on samples from the
antrum, the rapid urease test, and the 16S rRNA and glmM
polymerase chain reaction (PCR) were used to detect the
infections of H. pylori. Patients were considered H. pylori-
infected only if all four tests were positive.
3.3. Histological Examination
First, the sections from biopsy samples were immersed
in buffered formalin 10%. Then, Hematoxylin and Eosin
staining method was used to stain the sections for detec-
tion of the gastritis. Moreover, a Giemsa stain was applied
for H. pylori identification. An ulcer was defined as a lim-
ited mucosal impairment (with a diameter of > 5 mm and
apparent depth) covered with exudates in the duodenum
or stomach. The four-point Updated Sydney System (0: no;
1: mild; 2: moderate; and 3: severe changes) was utilized
to classify and grade the severity of gastritis, ranging from
normal to severe, according to the degree of mononuclear
cell (MNC) and polymorphonuclear leukocytes (PMN) infil-
tration, and atrophy (20).
3.4. DNA Extraction and NLRP3 rs10754558 Genotyping
The samples from corpus were used to extract the ge-
nomic DNA with the aid of biospin tissue genomic DNA ex-
traction kit (Bio Flux, Japan) acceding to the relevant pro-
tocol. A suspension was prepared from the extracted DNA
in ultra-pure RNAse/DNAse-Free distilled water. The NLRP3
rs10754558 polymorphism was genotyped by polymerase
chain reaction-restriction fragment length polymorphism
(PCR-RFLP) as previously described by Li et al. (21).The ther-
mal program of PCR process was a temperature of 95ºC for
5 minutes and then running 35 cycles at 95ºC for 30 sec-
onds, at 58ºC for 30 seconds, at 72ºC for 30 seconds, and
a final incubation at 72ºC for 5 minutes. In the next step,
the digestion was performed on 6 µL-aliquot of the prod-
uct using restriction enzyme MboI (Fermentas, Lithuania),
followed by electrophoresis with 8% polyacrylamide gel
to detect the NLRP3 rs10754558 alleles based on their size.
Other laboratory personnel repeated the genotyping using
randomly selected PCR samples in each genotype to verify
genotyping results, which showed no difference.
PCR-RFLP approach was employed to detect the sin-
gle nucleotide polymorphisms (SNP) of NLRP3. Single
nucleotide polymorphisms of NLRP3 was detected using
the PCR-RFLP procedure. PCR reaction was run with the
set-up program: at 95ºC for 5 minutes, and then 35 cy-
cles at 95ºC for 30 seconds, at 58ºC for 30 seconds, at
72ºC for 30 seconds, and a final incubation at 72ºC for
5 minutes. The primer for the PCR-RFLP was designed
using the genomic sequences based on the Gen Bank
(http://www.ncbi.nlm.nih.gov). The primer used for detec-
tion of SNP is shown in Table 1. To evaluate the accuracy
of obtained results, several samples were selected and re-
genotyped randomly.
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Table 1. Primers and Enzyme for Detecting the NLRP3 SNPa
SNP Primers Sequence Annealing Temperature Enzyme Restriction Enzyme Digest Fragment Size,
bp
rs10754558
F: 5-CAGGACAATGACAGCATCGGGTGTTGAT-3
58.5ºC MboI GG: 261; CG: 261; 236; CC: 236
R: 5-GCTGCCATAAAATTTCAACATAA-3
aPositive strand of nucleotide sequence was used to design primers for rs10754558. For the forward primer, a single nucleotide artificial mismatch was introduced within
the three bases closest to the 3’end (GTT→ GAT) to produce an MboI site.
3.5. Quantitative Analysis of IL-1β mRNA in the Gastric Mucosa
Using Real-Time PCR
In this study, 75 patients were selected to evaluate the
level of IL-1β in the gastric mucosa, which included 25 pa-
tients with GG genotype, 25 patients with GC genotype, and
25 patients with CC genotype of NLRP3 rs10754558 poly-
morphism. We took the same number of biopsies from pa-
tients with the ancestral allele (also called as wild allele),
which were fitted to the control group by sex, age, and
pathology. The total RNA extraction was carried out from
the biopsy samples with the aid of a TRIzol® Plus RNA Pu-
rification Kit based on corresponding protocol. Following
the treatment with DNase, 5µg of total RNA was left with 2
µL of Super Script II reverse transcriptase (Revert Aid First
cDNA synthesis (#K1632, Fermentase, Lithuania)). To nor-
malize the results of cytokine mRNA expression, the house
keeping gene of β-actin was used. The mRNA levels of cy-
tokine and β-actin was quantified by the RotorGene Q cy-
cler (Corbett Life Sciences; Doncaster, Australia) designed
for IL-1β, and β-actin expression, shown in Table 2.
Table 2. Primers and Probes Used in Real-Time PCR
Gene Primers Probes
β-
actin
F: 5-AGCCTCGCCTTTGCCGA-3 FAM-
CCGCCGCCCGTCCACACCCGCC-
TAMRAR: 5-CTGGTGCCTGGGGCG-3
IL-1β
F: 5-ACAGATGAAGTGCTCCTTCCA-3 FAM-
CTCTGCCCTCTGGATGGCGG-
TAMRAR: 5-GTCGGAGATTCGTAGCTGGAT-3
Reaction mixtures (25 µL) for PCR contained 1mg of
synthesized cDNA solution with Taqman probe master mix
(Qiagen, Germany). PCR was run at 95ºC for 10 minutes, and
then 45 cycles of 95ºC for 15 seconds, and 60ºC for 60sec-
onds, based on the manufacturer’s protocol. All experi-
ments were repeated twice and all cytokine experiments
were examined by analyzing all RNA samples in the same
test. Relative quantification of cytokine toβ-actin ratio (cy-
tokine mRNA/β-actinm RNA) was calculated in accordance
with the 2-∆∆C method (22).
3.6. SDS-PAGE and Western Blotting
Proteins were extracted using RIPA buffer. The sam-
ples after applying on the gel electrophoresis were trans-
ferred onto methanol-treated polyvinylidine difluoride
membranes with the aid of Trans-blot cell transfer sys-
tem (Bio-Rad, USA). Then, the immunolabeling procedure
was carried out on the resulting membranes using rabbit
anti-human polyclonal antibodies against β-actin (1:5000;
Abcam, England). Also, secondary antibody used in this
test was goat anti-rabbit IgG antibody coupled with HRP
(1:1000; Abcam, England). The probe of membranes was
done in line with the pierce ECL western blotting substrate
instruction (Thermo Scientific; Scoresby, Australia).
3.7. Statistical Analysis
The statistical analysis of the polymorphism frequency
was performed by Fisher’s exact test among the different
groups. The odds ratio (OR) was calculated to evaluate the
association of the polymorphisms and the diseases and the
results were expressed as OR with 95% confidence inter-
val (CI). The expression of cytokine was reported as mean
and standard deviation. The independent t-test was used to
analyze the differences between groups with and without
polymorphism. In all tests, P value of 0.05 was statistically
considered as significance level.
4. Results
4.1. Demographic Characterization of Studied Population
The general profiles of the studied population are
shown in Table 3. H. pylori-infection was detected in 64.7%
of the subjects. The statistical analysis of the groups pro-
vided the following results: the H. pylori-positive group
with gastritis (n = 237 with 110 males and 127 females and
the mean age of 50.18 ± 15.02 years); H. pylori-positive
group with peptic ulcer diseases (n = 63 with 35 males and
28 females and the mean age of 50.16 ± 15.3 years); H. py-
lori-negative group with non-ulcer dysplasia (n = 164 with
75 males and 89 females and the mean age of 50.96± 19.77
years).
4.2. Polyacrylamide Gel Electrophoresis of PCR-RFLP to Deter-
mine the NLRP3 rs10754558 Genotyping
PCR products was digested by MboI enzyme to distin-
guish the NLRP3 rs10754558. The product length of PCR re-
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Table 3. Characteristics of Patients with Helicobacter pylori Infection and Control
Subjects
Characteristics
Patients Control
Subjects
Gastritis Peptic Ulcer
Diseases
Male/female,
No.
110/127 35/28 75/89
Age, y (mean±
SD)
50.18± 15.02 50.16± 15.3 50.96± 19.77
Total, No. (%) 237 (51) 63 (13.5) 164 (35.3)
action for rs10754558 was 261 bp. For homozygous wild-
type (GG), the enzyme does not work, and there will be a
single band with 261 bp. For homozygous mutant geno-
type (CC), the enzyme cuts the two alleles, and the PCR
product will appear as a single band of 236 bp, whereas the
heterozygous genotype (GC) will appear as two bands of
261 and 236 bp (Figure 1).
4.3. Evaluation of NLRP3 rs10754558 Genotyping and Helicobac-
ter pylori Infection Susceptibility
The frequency of three genotypes of NLRP3rs10754558
was assessed in both patient and control groups. The
results are shown in Table 4. No significant differ-
ence was observed in the genotype of the polymorphism
NLRP3rs10754558 between infected individuals and con-
trol subjects. Among the three genotypes of polymor-
phism, the frequency of GC was higher than the other two
in both patients and control groups.
4.4. Evaluation NLRP3 rs10754558 Polymorphism and Suscep-
tibility to Gastritis and Peptic Ulcer Diseases in Helicobacter
pylori-Infected Patients
Frequency of different genotypes of NLRP3rs10754558
polymorphism based on H. pylori infection and the type of
disease caused by it are presented in Table 5. Statistical data
indicated no significant association of the polymorphism
frequency and the disease types in infected subjects with
H. pylori.
4.5. Evaluation of NLRP3 rs10754558 Polymorphism and Cellular
Infiltration in Helicobacter pylori-Infected Patients
In current study was observed the relationship be-
tween NLRP3 (rs10754558) polymorphism and the rate of
migration of inflammatory cells, which points out acute
and chronic inflammation in the infected individuals with
H. pylori (Table 6). The degree of acute inflammation in
infected individuals with H. pylori with GG genotype was
higher than those infected with GC and CC genotypes (P
= 0.016), however; no significant correlation was found
between NLRP3 rs10754558 polymorphism and chronic in-
flammatory severity (P = 0.979).
Figure 1. PCR-RFLP polyacrylamide gel electrophoresis of the NLRP3 rs10754558
polymorphism indicating: N: PCR product without enzyme, M: 100 bp DNA Ladder
Marker, No: 2 and 3 (CC = 236 bp), No: 1 (GC = 261 bp and 236 bp) and No: 4 (GG = 261
bp) genotypes
4.6. Mucosal IL-1β mRNA Levels in Gastric Mucosa
IL-1β mRNA levels was measured in two groups (Fig-
ure 2). IL-1β mRNA was elevated in infected subjects as
compared to uninfected controls. In addition, the results
showed that the expression of IL-1β in patients was 2.18-
folded higher than that in the control subjects.
4.7. The Effect of NLRP3 rs10754558 Polymorphism on the Expres-
sion of IL-1β in Helicobacter pylori-Infected Patients with Gas-
tritis and Peptic Ulcer Diseases
The function of NLRP3 genes might be influenced by
the polymorphisms, so the hypothesis of the present study
was that the polymorphisms might change the IL-1β ex-
pression in the gastric mucosa. Hence, the study evaluated
whether the variants of NLRP3 allele’s modified the expres-
sion of IL-1β in infected patients with gastritis and peptic
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Table 4. The Frequency of Different Genotypes of NLRP3rs10754558 in Two Groups of Patients and Controls
NLRP3 (rs10754558) Genotype H. pylori Infected, No. (%) H. pylori Uninfected, No. (%) P Value OR (95% CI)
CC 71 (23.7) 44 (26.8) 0.451 0.846 (0.547 - 1.308)
CG 148 (49.3) 82 (50) 0.891 0.974 (0.665 - 1.425)
GG 81 (27) 38 (23.2) 0.367 1.226 (0.787 - 1.911)
Table 5. Frequency of NLRP3rs10754558 Polymorphism and Type of Disease in Infected Patients
NLRP3 (rs10754558) Genotype Infected Patients with Gastritis, No. (%) Infected Patients with PUD, No. (%) P Value OR (95% CI)
CC 56 (23.6) 15 (23.8) 0.976 0.990 (0.515 - 1.902)
CG 115 (48.5) 33 (52.4) 0.584 0.857 (0.491 - 1.494)
GG 66 (27.8) 15 (23.8) 0.521 1.235 (0.648 - 2.355)
Table 6. The Association of NLRP3 (rs10754558) Polymorphism with Acute and
Chronic Inflammation in Infected Patients with Helicobacter pyloria , b
NLRP3 (rs10754558)
Genotype
Chronic
Inflammation
Acute Inflammation
CC 2.04± 0.155 0.74± 0.174
CG 2.04± 0.107 1.15± 0.107
GG 2.07± 0.103 1.37± 0.152
P value 0.979 0.016
aValues are expressed as mean± SD.
bThe rate of inflammation is in the range (0-3).
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Figure 2. Expression of IL-1β mRNA in patients and control group. A level of cy-
tokines was increased in infected group compare to control group (P value < 0.05).
ulcer diseases. Our results in infected patients with gastri-
tis and peptic ulcer diseases demonstrated no significant
expression of IL-1β between infected patients with SNPs in
NLRP3 and the wild-type allele (Figure 3).
4.8. The Effect of NLRP3 rs10754558 Polymorphism on IL-1β Pro-
tein in Infected Patients with Gastritis
Western blotting was performed to detect the level of
IL-1β protein in 75 infected patients with three different
genotypes of polymorphism (25 subjects from each geno-
type). No significant differences were obtained between
these 3 groups in infected patients with gastritis (Figures
4 and 5).
5. Discussion
Helicobacter pylori as an infectious agent in the gastric
mucosa cause the infiltration of neutrophils, lymphocytes,
monocytes and plasma cells. The results of previous stud-
ies have shown that the activation and the migration of
inflammatory cells toward the gastric mucosa depend on
the production of pro-inflammatory cytokines (7, 22, 23).
On this note, molecular structures of inflammasomes, that
play a prominent role in identifying pathogens and incit-
ing stronger immune responses, are formed (24). Accord-
ing to reports, the polymorphisms in the NLRP3 gene could
increase the susceptibility to some inflammatory diseases
such as ulcerative colitis, juvenile idiopathic arthritis, in-
flammatory bowel disease, neonatal onset multisystem in-
flammatory disease, and type 2 diabetes (18, 25-29). Inter-
estingly, in the present study, there were conflicting results
with the aforementioned findings, such that there was no
association between NLRP3 rs10754558 and H. pylori infec-
tions or diseases related to this microorganism.
Kim et al. (30) reported that H. pylori could induce the
secretion of IL-1β in the innate immune cells, which sym-
bolizes the NLRP3 inflammasome activity and needs the
Cag Pathogenicity Island. The study of Castano-Rodriguez
et al. (31) have shown the correlation between host ge-
netic factors in gastric diseases caused by H. pylori infec-
tion, which revealed that the polymorphisms in genes in-
volved in the nucleotide-binding oligomerization domain
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Figure 3. The expression of IL-1β between infected patients with SNPs in NLRP3 and infected patients with the wild-type allele. IL-1β production levels are not significantly
different in various genotypes of polymorphism in infected patients with gastritis (A) and peptic ulcer disease (B). The mRNA expression of IL-1βwas evaluated using real-time
PCR.
Figure 4. Level of IL-1β protein produced in the patients. No significant differences
were observed between the levels of cytokine in gene polymorphism in the infected
groups.
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Figure 5. Expression of IL-1β by Western blot analysis in freshly obtained hu-
man gastric biopsies of H. pylori-infected patients with gastritis (25 subjects from
each genotype). β-actin was used as loading control. Values are expressed as ar-
bitrary units (a.u.). The horizontal bar represents the mean level of respective
NLRP3genotype.
(NOD)-like receptor signaling pathway are related with in-
fection caused by H. pylori among the ethnic Chinese peo-
ple. They also showed the association of H. pylori strains
with gastric cancer and gastritis, as well as found different
levels of the expression of cytokines and chemokines. Heli-
cobacter pylori, which causes the gastritis and peptic ulcer,
is detected by PRRs, so the role of molecule involved in the
NOD-like receptor (NLR) signaling pathway, NLRP3, was in-
vestigated in these diseases.
Zhang et al. (18) revealed that rs10754558 of NLRP3 is
a crucial factor that can affect the development of ulcera-
tive colitis in a Chinese population. Deng et al. (19) also
reported the association of GG genotype of rs3806268 in
NLRP3 gene with the elevated risk of primary gout in Chi-
nese people. Zheng et al. (32) reported the overexpres-
sion of NLRP3 in aorta of patients suffering from coronary
atherosclerosis and the correlation of aortic NLRP3 expres-
sion with the disease severity. Furthermore, Zhou et al. (17)
showed that the G allele of NLRP3rs10754558 is related with
the onset and poor prognosis of coronary artery disease
(CAD) in Chinese Han population. They have also shown
that the G allele susceptibility to CAD is associated with an
increase in serum level of IL-1β in CAD. Current evidence
suggests that polymorphisms involved in NLRP3 inflam-
masome may play a role in the prognosis or progression
of some diseases. Therefore, it was hypothesized that func-
tional SNPs in NALP3 inflammasome may be involved in the
severity of the type of diseases caused by H. pylori, by in-
creasing or reducing cytokines secretion. At first, the ex-
pression of IL-1β and IL-18 genes between uninfected and
H. pylori infected individuals were compared. It was found
that these cytokines were incremented in the patients in-
fected with H. pylori in comparison with healthy controls,
consistent with studies of Hitzler et al. (13). They have
shown the activation of caspase-1 by H. pylori and thus IL-
1β/IL-18 secretion in dendritic cells (DCs) in the in vitro and
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also in the in vivo conditions. Two studies recently con-
ducted on the H. pylori-infected human gastric cell lines in-
dicated an increased expression of caspase-1, IL-1β, and IL-18
(33, 34).
Furthermore, no association was found between H. py-
lori infection and NLRP3-rs10754558, as well as between SNP
and the type of diseases caused by H. pylori infection such
as gastritis and duodenal ulcer. This was in agreement with
other previous findings, which did not show any associa-
tion between this polymorphism and diseases such as in-
flammatory bowel disease (IBD), Crohn disease, and gout
(18, 19). While some other studies have shown the associa-
tion between this polymorphism and diseases such as gas-
tric cancer and ulcerative colitis (18, 31). Our findings show
that NLRP3 rs10754558 polymorphism may be involved in
the severity of some diseases caused by H. pylori infection.
5.1. Conclusions
Our findings show that rs10754558 polymorphism
might not participate in regulating inflammation and im-
mune responses in patients with H. pylori by influencing
the expression of components of the NLRP3 inflamma-
some.
Acknowledgments
The authors are grateful to the staffs of Cellular and
Molecular Research Center, Shahrekord University of Med-
ical Sciences and the authorities of the Endoscopy Unit of
Shahrekord Hajar Hospital for their valuable helps.
Footnotes
Authors’ Contribution: Hedayatollah Shirzad designed
the project and submitted it in the Shahrekord University
of Medical Sciences. Mahdieh Abolfathi and Ghorbanali
Rahimian collected the study samples. Mahdieh Abolfathi,
Nader Bagheri, Soleyman Kheyri, and Amin Soltani per-
formed the experiments and data analysis. Hedayatol-
lah Shirzad, Mahdieh Abolfathi, and Sara Iranparast con-
tributed in preparation of this paper.
Conflict of Interests: No conflict of interests was declared
by the authors.
Ethical Approval: This study was conducted at Cellular
and Molecular Research Center, Shahrekord University of
Medical Sciences. The research additionally was approved
by the ethical board of Shahrekord University of Medical
Sciences (grant: 2126 and IR.SKUMS.REC.1396.60).
Funding/Support: This work was supported by
Shahrekord University of Medical Sciences (grants No.
2126).
References
1. Bagheri N, Azadegan-Dehkordi F, Rahimian G, Rafieian-Kopaei M,
Shirzad H. Role of regulatory T-cells in different clinical expressions
of helicobacter pylori infection. Arch Med Res. 2016;47(4):245–54. doi:
10.1016/j.arcmed.2016.07.013. [PubMed: 27664483].
2. Bagheri N, Sadeghiani M, Rahimian G, Mahsa M, Shafigh M, Rafieian-
Kopaei M, et al. Correlation between expression of MMP-9 and
MMP-3 in Helicobacter pylori infected patients with different gas-
troduodenal diseases. Arab J Gastroenterol. 2018;19(4):148–54. doi:
10.1016/j.ajg.2018.11.001. [PubMed: 30509760].
3. Peek RJ, Blaser MJ. Helicobacter pylori and gastrointestinal tract ade-
nocarcinomas. Nat Rev Cancer. 2002;2(1):28–37. doi: 10.1038/nrc703.
[PubMed: 11902583].
4. Bagheri N, Azadegan-Dehkordi F, Rafieian-Kopaei M, Rahimian G,
Asadi-Samani M, Shirzad H. Clinical relevance of Helicobacter pylori
virulence factors in Iranian patients with gastrointestinal diseases.
Microb Pathog. 2016;100:154–62. doi: 10.1016/j.micpath.2016.09.016.
[PubMed: 27666510].
5. Wroblewski LE, Peek RJ, Wilson KT. Helicobacter pylori and gas-
tric cancer: Factors that modulate disease risk. Clin Microbiol Rev.
2010;23(4):713–39. doi: 10.1128/CMR.00011-10. [PubMed: 20930071].
[PubMed Central: PMC2952980].
6. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis.
J Gastroenterol. 2009;44(4):239–48. doi: 10.1007/s00535-009-0014-1.
[PubMed: 19271114].
7. Bagheri N, Salimzadeh L, Shirzad H. The role of T helper 1-cell re-
sponse in Helicobacter pylori-infection. Microb Pathog. 2018;123:1–8.
doi: 10.1016/j.micpath.2018.06.033. [PubMed: 29936093].
8. Suzuki T, Kato K, Ohara S, Noguchi K, Sekine H, Nagura H, et al. Lo-
calization of antigen-presenting cells in Helicobacter pylori-infected
gastric mucosa. Pathol Int. 2002;52(4):265–71. doi: 10.1046/j.1440-
1827.2002.01347.x. [PubMed: 12031081].
9. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter
pylori antibodies in humans. Ann Intern Med. 1988;109(1):11–7. doi:
10.7326/0003-4819-109-1-11. [PubMed: 3288028].
10. Bagheri N, Shirzad H, Elahi S, Azadegan-Dehkordi F, Rahimian G,
Shafigh M, et al. Downregulated regulatory T cell function is asso-
ciated with increased peptic ulcer in Helicobacter pylori-infection.
Microb Pathog. 2017;110:165–75. doi: 10.1016/j.micpath.2017.06.040.
[PubMed: 28666843].
11. Castano-Rodriguez N, Kaakoush NO, Mitchell HM. Pattern-
recognition receptors and gastric cancer. Front Immunol. 2014;5:336.
doi: 10.3389/fimmu.2014.00336. [PubMed: 25101079]. [PubMed
Central: PMC4105827].
12. Yang CS, Shin DM, Jo EK. The Role of NLR-related Protein 3 inflam-
masome in host defense and inflammatory diseases. Int Neurourol
J. 2012;16(1):2–12. doi: 10.5213/inj.2012.16.1.2. [PubMed: 22500248].
[PubMed Central: PMC3321399].
13. Hitzler I, Sayi A, Kohler E, Engler DB, Koch KN, Hardt WD, et al. Caspase-
1 has both proinflammatory and regulatory properties in Helicobac-
ter infections, which are differentially mediated by its substrates
IL-1beta and IL-18. J Immunol. 2012;188(8):3594–602. doi: 10.4049/jim-
munol.1103212. [PubMed: 22403439].
14. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health
and disease. Nature. 2012;481(7381):278–86. doi: 10.1038/nature10759.
[PubMed: 22258606].
15. McCall SH, Sahraei M, Young AB, Worley CS, Duncan JA, Ting JP,
et al. Osteoblasts express NLRP3, a nucleotide-binding domain
and leucine-rich repeat region containing receptor implicated in
bacterially induced cell death. J Bone Miner Res. 2008;23(1):30–40.
doi: 10.1359/jbmr.071002. [PubMed: 17907925]. [PubMed Central:
PMC2663588].
Jundishapur J Microbiol. In Press(In Press):e88231. 7
Uncorrected Proof
Abolfathi M et al.
16. Bagheri N, Azadegan-Dehkordi F, Rahimian G, Hashemzadeh-
Chaleshtori M, Rafieian-Kopaei M, Kheiri S, et al. Altered Th17
cytokine expression in helicobacter pylori patients with TLR4
(D299G) polymorphism. Immunol Invest. 2016;45(2):161–71. doi:
10.3109/08820139.2015.1122615. [PubMed: 26853914].
17. Zhou D, Wang X, Chen T, Wen W, Liu Y, Wu Y, et al. The NLRP3
rs10754558 polymorphism is associated with the occurrence and
prognosis of coronary artery disease in the Chinese Han Population.
Biomed Res Int. 2016;2016:3185397. doi: 10.1155/2016/3185397. [PubMed:
27110561]. [PubMed Central: PMC4823501].
18. Zhang HX, Wang ZT, Lu XX, Wang YG, Zhong J, Liu J. NLRP3 gene
is associated with ulcerative colitis (UC), but not Crohn’s disease
(CD), in Chinese Han population. Inflamm Res. 2014;63(12):979–85. doi:
10.1007/s00011-014-0774-9. [PubMed: 25297810].
19. Deng J, Lin W, Chen Y, Wang X, Yin Z, Yao C, et al. rs3806268 of NLRP3
gene polymorphism is associated with the development of primary
gout. Int J Clin Exp Pathol. 2015;8(10):13747–52. [PubMed: 26722603].
[PubMed Central: PMC4680548].
20. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grad-
ing of gastritis. The updated Sydney System. International Work-
shop on the Histopathology of Gastritis, Houston 1994. Am J Surg
Pathol. 1996;20(10):1161–81. doi: 10.1097/00000478-199610000-00001.
[PubMed: 8827022].
21. Li L, Yu H, Jiang Y, Deng B, Bai L, Kijlstra A, et al. Genetic varia-
tions of NLR family genes in behcet’s disease. Sci Rep. 2016;6:20098.
doi: 10.1038/srep20098. [PubMed: 26833430]. [PubMed Central:
PMC4735577].
22. Bagheri N, Razavi A, Pourgheysari B, Azadegan-Dehkordi F, Rahimian
G, Pirayesh A, et al. Up-regulated Th17 cell function is associated
with increased peptic ulcer disease in Helicobacter pylori-infection.
Infect Genet Evol. 2018;60:117–25. doi: 10.1016/j.meegid.2018.02.020.
[PubMed: 29481961].
23. Yamaoka Y, Yamauchi K, Ota H, Sugiyama A, Ishizone S, Gra-
ham DY, et al. Natural history of gastric mucosal cytokine ex-
pression in Helicobacter pylori gastritis in Mongolian gerbils. In-
fect Immun. 2005;73(4):2205–12. doi: 10.1128/IAI.73.4.2205-2212.2005.
[PubMed: 15784564]. [PubMed Central: PMC1087449].
24. Abdelaziz DH, Khalil H, Cormet-Boyaka E, Amer AO. The cooperation
between the autophagy machinery and the inflammasome to im-
plement an appropriate innate immune response: Do they regulate
each other? Immunol Rev. 2015;265(1):194–204. doi: 10.1111/imr.12288.
[PubMed: 25879294]. [PubMed Central: PMC4747236].
25. Varghese GP, Uporova L, Halfvarson J, Sirsjo A, Fransen K. Polymor-
phism in the NLRP3 inflammasome-associated EIF2AK2 gene and
inflammatory bowel disease. Mol Med Rep. 2015;11(6):4579–84. doi:
10.3892/mmr.2015.3236. [PubMed: 25607115].
26. Yang CA, Huang ST, Chiang BL. Association of NLRP3 and CARD8
genetic polymorphisms with juvenile idiopathic arthritis in a
Taiwanese population. Scand J Rheumatol. 2014;43(2):146–52. doi:
10.3109/03009742.2013.834962. [PubMed: 24295199].
27. Haneklaus M, O’Neill LA, Coll RC. Modulatory mechanisms
controlling the NLRP3 inflammasome in inflammation: Re-
cent developments. Curr Opin Immunol. 2013;25(1):40–5. doi:
10.1016/j.coi.2012.12.004. [PubMed: 23305783].
28. Dehghan A, Yang Q, Peters A, Basu S, Bis JC, Rudnicka AR, et al.
Association of novel genetic Loci with circulating fibrinogen lev-
els: A genome-wide association study in 6 population-based co-
horts. Circ Cardiovasc Genet. 2009;2(2):125–33. doi: 10.1161/CIRCGENET-
ICS.108.825224. [PubMed: 20031576]. [PubMed Central: PMC2764985].
29. Zheng Y, Zhang D, Zhang L, Fu M, Zeng Y, Russell R. Variants
of NLRP3 gene are associated with insulin resistance in Chinese
Han population with type-2 diabetes. Gene. 2013;530(1):151–4. doi:
10.1016/j.gene.2013.07.082. [PubMed: 23973727].
30. Kim DJ, Park JH, Franchi L, Backert S, Nunez G. The Cag pathogenic-
ity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-
1beta production in Helicobacter pylori infected dendritic cells. Eur
J Immunol. 2013;43(10):2650–8. doi: 10.1002/eji.201243281. [PubMed:
23818043]. [PubMed Central: PMC3797179].
31. Castano-Rodriguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell
HM. The NOD-like receptor signalling pathway in Helicobacter py-
lori infection and related gastric cancer: A case-control study
and gene expression analyses. PLoS One. 2014;9(6). e98899. doi:
10.1371/journal.pone.0098899. [PubMed: 24901306]. [PubMed Cen-
tral: PMC4047072].
32. Zheng F, Xing S, Gong Z, Xing Q. NLRP3 inflammasomes show high
expression in aorta of patients with atherosclerosis. Heart Lung Circ.
2013;22(9):746–50. doi: 10.1016/j.hlc.2013.01.012. [PubMed: 23462287].
33. Shimada M, Ando T, Peek RM, Watanabe O, Ishiguro K, Maeda O,
et al. Helicobacter pylori infection upregulates interleukin-18 pro-
duction from gastric epithelial cells. Eur J Gastroenterol Hepatol.
2008;20(12):1144–50. doi: 10.1097/MEG.0b013e32830edb15. [PubMed:
18946358]. [PubMed Central: PMC3372857].
34. Yang JC, Yang HC, Shun CT, Wang TH, Chien CT, Kao JY. catechins and
sialic acid attenuate Helicobacter pylori-triggered epithelial caspase-
1 activity and eradicate Helicobacter pylori infection. Evid Based
Complement Alternat Med. 2013;2013:248585. doi: 10.1155/2013/248585.
[PubMed: 23653660]. [PubMed Central: PMC3638598].
8 Jundishapur J Microbiol. In Press(In Press):e88231.
